The Patent Finder

Abuse-Deterrent Drug Formulations

Collegium Pharmaceutical, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 7,771,707Abuse-Deterrent Drug Formulations
In force
 · High confidence
UsedRemaining
Collegium Pharmaceutical, Inc.In forceHigh confidence
US 8,840,928Tamper-Resistant Pharmaceutical Compositions of Opiods and Other Drugs
Term ended · USPTO later recorded non-payment Oct 26, 2026
Term ended Jul 7, 2023 · High confidence
Collegium Pharmaceutical, Inc.Term ended
USPTO later recorded non-payment Oct 26, 2026
Term ended Jul 7, 2023High confidence
US 9,044,398Abuse-Deterrent Pharmaceutical Compositions of Opioids and Other Drugs
Term ended
Term ended Jul 7, 2023 · High confidence
Collegium Pharmaceutical, Inc.Term endedTerm ended Jul 7, 2023High confidence
US 9,248,195Abuse-Deterrent Pharmaceutical Compositions of Opioids and Other Drugs
Term ended · USPTO later recorded non-payment Mar 11, 2024
Term ended Jul 7, 2023 · High confidence
Collegium Pharmaceutical, Inc.Term ended
USPTO later recorded non-payment Mar 11, 2024
Term ended Jul 7, 2023High confidence
US 9,592,200Abuse-Deterrent Pharmaceutical Compositions of Opioids and Other Drugs
Term ended · USPTO later recorded non-payment Apr 21, 2025
Term ended Jul 7, 2023 · High confidence
Collegium Pharmaceutical, Inc.Term ended
USPTO later recorded non-payment Apr 21, 2025
Term ended Jul 7, 2023High confidence
US 9,682,075Tamper-Resistant Pharmaceutical Compositions of Opioids and Other Drugs
Term ended
Term ended Jul 7, 2023 · High confidence
Collegium Pharmaceutical, Inc.Term endedTerm ended Jul 7, 2023High confidence
US 9,763,883Abuse-Deterrent Drug Formulations
Term ended
Term ended Jul 7, 2023 · High confidence
Collegium Pharmaceutical, Inc.Term endedTerm ended Jul 7, 2023High confidence
US 10,004,729Tamper-Resistant Pharmaceutical Compositions of Opioids and Other Drugs
Term ended
Term ended Jul 7, 2023 · High confidence
Collegium Pharmaceutical, Inc.Term endedTerm ended Jul 7, 2023High confidence
US 10,525,052Abuse-Deterrent Drug Formulations
Term ended
Term ended Jul 7, 2023 · High confidence
Collegium Pharmaceutical, Inc.Term endedTerm ended Jul 7, 2023High confidence
US 10,525,053Abuse-Deterrent Pharmaceutical Compositions of Opioids and Other Drugs
Term ended · USPTO later recorded non-payment Feb 12, 2024
Term ended Jul 7, 2023 · High confidence
Collegium Pharmaceutical, Inc.Term ended
USPTO later recorded non-payment Feb 12, 2024
Term ended Jul 7, 2023High confidence
21 more records in this group · Pro
10 of 31 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 31, including 14 expired.
Upgrade to Pro
1 of these is in force and held by Collegium Pharmaceutical, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited